| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC UNSPECIFIED ION MODE | CR02_056 | Genotype:Fh1-/-CL19 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_057 | Genotype:Fh1-/-CL19 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_058 | Genotype:Fh1-/-CL19 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_059 | Genotype:Fh1-/-CL19 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_060 | Genotype:Fh1-/-CL19 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_051 | Genotype:Fh1-/-CL19 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_052 | Genotype:Fh1-/-CL19 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_053 | Genotype:Fh1-/-CL19 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_054 | Genotype:Fh1-/-CL19 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_055 | Genotype:Fh1-/-CL19 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_046 | Genotype:Fh1-/-CL1 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_047 | Genotype:Fh1-/-CL1 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_048 | Genotype:Fh1-/-CL1 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_049 | Genotype:Fh1-/-CL1 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_050 | Genotype:Fh1-/-CL1 | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_041 | Genotype:Fh1-/-CL1 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_042 | Genotype:Fh1-/-CL1 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_043 | Genotype:Fh1-/-CL1 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_044 | Genotype:Fh1-/-CL1 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_045 | Genotype:Fh1-/-CL1 | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_036 | Genotype:Fh1fl/fl | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_037 | Genotype:Fh1fl/fl | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_038 | Genotype:Fh1fl/fl | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_039 | Genotype:Fh1fl/fl | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_040 | Genotype:Fh1fl/fl | Treatment:siFoxa2 | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_031 | Genotype:Fh1fl/fl | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_032 | Genotype:Fh1fl/fl | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_033 | Genotype:Fh1fl/fl | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_034 | Genotype:Fh1fl/fl | Treatment:siNT | peak area |
| HILIC UNSPECIFIED ION MODE | CR02_035 | Genotype:Fh1fl/fl | Treatment:siNT | peak area |
Return to study ST002199 main page
Download data matrix(FOXA2 controls the anti-oxidant response in FH-deficient cells independent of NRF2 HILIC UNSPECIFIED ION MODE)
- Metabolomics Workbench
|